Literature DB >> 1422338

Antenatal screening for Down's syndrome.

V J Macri, R Clark.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1422338      PMCID: PMC1883382          DOI: 10.1136/bmj.305.6856.768-b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Early detection of Down's syndrome using free beta human choriogonadotropin.

Authors:  K Spencer; J N Macri
Journal:  Ann Clin Biochem       Date:  1992-05       Impact factor: 2.057

2.  Risk of Down's syndrome and amniocentesis rate.

Authors:  K Spencer; P Carpenter
Journal:  BMJ       Date:  1992-03-07

3.  Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin.

Authors:  J N Macri; R V Kasturi; D A Krantz; E J Cook; N D Moore; J A Young; K Romero; J W Larsen
Journal:  Am J Obstet Gynecol       Date:  1990-10       Impact factor: 8.661

4.  Prenatal screening for Down's syndrome.

Authors: 
Journal:  BMJ       Date:  1991-08-24

5.  Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.

Authors:  N J Wald; A Kennard; J W Densem; H S Cuckle; T Chard; L Butler
Journal:  BMJ       Date:  1992-08-15
  5 in total
  1 in total

1.  Using decision analysis to compare policies for antenatal screening for Down's syndrome.

Authors:  J Fletcher; N R Hicks; J D Kay; P A Boyd
Journal:  BMJ       Date:  1995-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.